Citas bibligráficas
Lopez, H., (2021). Oxigenoterapia de alto flujo en pacientes con insuficiencia respiratoria aguda por COVID-19 [Tesis, Universidad Privada Antenor Orrego - UPAO]. https://hdl.handle.net/20.500.12759/7669
Lopez, H., Oxigenoterapia de alto flujo en pacientes con insuficiencia respiratoria aguda por COVID-19 [Tesis]. PE: Universidad Privada Antenor Orrego - UPAO; 2021. https://hdl.handle.net/20.500.12759/7669
@misc{renati/379831,
title = "Oxigenoterapia de alto flujo en pacientes con insuficiencia respiratoria aguda por COVID-19",
author = "Lopez Puescas, Hilario Ygnacio",
publisher = "Universidad Privada Antenor Orrego - UPAO",
year = "2021"
}
Introduction: In December 2019, a new species of coronavirus was identified as Coronavirus 2 of Severe Acute Respiratory Syndrome (SARS-CoC-2), which causes atypical pneumonias among residents of the city of Wuhan, China. Severe new coronavirus 2019 (COVID-19) disease often progresses to acute hypoxemic respiratory failure requiring high fractional inspired oxygen concentration and consideration of noninvasive ventilation strategies. In this context, high-flow oxygen therapy via highflow nasal cannula may reduce the need for invasive ventilation and associated adverse events, such as ventilator-associated pneumonias, and also relieve stress on healthcare systems during the COVID-19 pandemic. Objective: To review the evidence on the use of high-flow oxygen therapy in patients with acute respiratory failure from COVID-19 available through July 2020. Method: A narrative review study was conducted to evaluate reliable scientific evidence on the topic. To do so, studies from journals that are indexed in databases such as Pubmed/Medline, Scopus, Scielo were reviewed. Conclusions: The use of high-flow nasal cannula with a surgical mask on the patient's face could be a reasonable practice that could benefit hypoxemic patients with COVID19 and avoid intubation.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons